Co-investigator NCRN investigator led clinical trial: A phase IIa study of RItuximab and VArlilumab in relapsed or refractory B-cell malignancies (RIVA trial)
- Kim Linton (Contributor)
Activity: Internal positions, career professional development, other peer review and other › Other › Research